Anti-Complement component C9 (human)

Anti-Complement component C9 (human)

Cat. No.

Cat. No.

Cat. No.

ABS 004-53

ABS 004-53

ABS 004-53

Product name

Product name

Product name

Anti-Complement component C9 (human)

Anti-Complement component C9 (human)

Anti-Complement component C9 (human)

Description

Description

Description

Mouse monoclonal antibody

Mouse monoclonal antibody

Mouse monoclonal antibody

Mouse monoclonal antibody

Specificity

Specificity

Specificity

ABS 004-53 is specific for complement factor C9

ABS 004-53 is specific for complement factor C9

ABS 004-53 is specific for complement factor C9

ABS 004-53 is specific for complement factor C9

Immunogen

Immunogen

Immunogen

Complement factor C9

Complement factor C9

Complement factor C9

Complement factor C9

Application

Application

Application

ELISA

ELISA

ELISA

Species reactivity (positive)

Species reactivity (positive)

Species reactivity (positive)

Human

Human

Human

Species reactivity (negative)

Species reactivity (negative)

Species reactivity (negative)

Not determined

Not determined

Not determined

Subclass

Subclass

Subclass

IgG1/k

IgG1/k

IgG1/k

IgG1/k

Gene ID

Gene ID

Gene ID

735

735

735

Clone number

Clone number

Clone number

C9 53

C9 53

C9 53

Epitope

Epitope

Epitope

Not determined

Not determined

Not determined

Not determined

Content

Content

Content

Available in 200 µL and 1 mL size.1 mg/mL +/- 15%. See Certificate of Analysis for details.

Available in 200 µL and 1 mL size.1 mg/mL +/- 15%. See Certificate of Analysis for details.

Available in 200 µL and 1 mL size.1 mg/mL +/- 15%. See Certificate of Analysis for details.

Available in 200 µL and 1 mL size.1 mg/mL +/- 15%. See Certificate of Analysis for details.

Purification

Purification

Purification

Protein-A purified

Protein-A purified

Protein-A purified

Form

Form

Form

Liquid

Liquid

Liquid

Solvent

Solvent

Solvent

0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide

0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide

0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide

Storage

Storage

Storage

4-8ºC without exposure to light. No precautions necessary during handling.

4-8ºC without exposure to light. No precautions necessary during handling.

4-8ºC without exposure to light. No precautions necessary during handling.

Target

Target

Target

Complement factor C9 is a 71kDa single-chain ellipsoid a-globular molecule of 558 amino acids including a leader sequence of 20 amino acids. C9 bind the C5b8 complex on membranes and has an unique property in forming tubular structures containing between 12 and 18 monomers, closely resembling the membrane attack complex (MAC). The primary site of synthesis is hepatocytes, secondary sites are monocytes, fibroblasts and glial cells. The normal level of C9 in plasma is 60 µg/mL, and the level is up regulated from hepatocytes by IFN-g.

Complement factor C9 is a 71kDa single-chain ellipsoid a-globular molecule of 558 amino acids including a leader sequence of 20 amino acids. C9 bind the C5b8 complex on membranes and has an unique property in forming tubular structures containing between 12 and 18 monomers, closely resembling the membrane attack complex (MAC). The primary site of synthesis is hepatocytes, secondary sites are monocytes, fibroblasts and glial cells. The normal level of C9 in plasma is 60 µg/mL, and the level is up regulated from hepatocytes by IFN-g.

Complement factor C9 is a 71kDa single-chain ellipsoid a-globular molecule of 558 amino acids including a leader sequence of 20 amino acids. C9 bind the C5b8 complex on membranes and has an unique property in forming tubular structures containing between 12 and 18 monomers, closely resembling the membrane attack complex (MAC). The primary site of synthesis is hepatocytes, secondary sites are monocytes, fibroblasts and glial cells. The normal level of C9 in plasma is 60 µg/mL, and the level is up regulated from hepatocytes by IFN-g.

Complement factor C9 is a 71kDa single-chain ellipsoid a-globular molecule of 558 amino acids including a leader sequence of 20 amino acids. C9 bind the C5b8 complex on membranes and has an unique property in forming tubular structures containing between 12 and 18 monomers, closely resembling the membrane attack complex (MAC). The primary site of synthesis is hepatocytes, secondary sites are monocytes, fibroblasts and glial cells. The normal level of C9 in plasma is 60 µg/mL, and the level is up regulated from hepatocytes by IFN-g.